SCIENCE@home

Susceptibility of pancreatic cancer stem cells to reprogramming

Kozo Noguchi,H. Eguchi,M. Konno,K. Kawamoto,N. Nishida,Jun Koseki,H. Wada,S. Marubashi,H. Nagano,Y. Doki,M. Mori,H. Ishii

Published 2015 in Cancer Science

ABSTRACT

Previous reports have indicated that reprogramming technologies may be useful for altering the malignant phenotype of cancer cells. Although somatic stem cells in normal tissues are more sensitive to reprogramming induction than differentiated cells, it remains to be elucidated whether any specific subpopulations are sensitive to reprogramming in heterogeneous tumor tissues. Here we examined the susceptibility of pancreatic cancer stem cells (CSC) and non‐CSC to reprogramming. To characterize CSC populations, we focused on c‐Met signaling, which has been identified as a marker of CSC in mouse experiments in vivo. Cells that expressed high levels of c‐Met showed higher CSC properties, such as tumor‐initiating capacity, and resistance to gemcitabine. Real‐time reverse transcription‐polymerase chain reaction in cells expressing high levels of c‐Met revealed endogenous expression of reprogramming factors, such as OCT3/4, SOX2, KLF4 and cMYC. Introduction of these four factors resulted in higher alkaline phosphatase staining in cells with high c‐Met expression than in controls. Therefore, the study results demonstrate that cellular reprogramming may be useful for extensive epigenetic modification of malignant features of pancreatic CSC.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-25 of 25 references · Page 1 of 1

CITED BY

Showing 1-30 of 30 citing papers · Page 1 of 1